Beigene Ltd (NASDAQ:BGNE)

178.00
Delayed Data
As of Jun 24
 +21.80 / +13.96%
Today’s Change
118.18
Today|||52-Week Range
426.56
-34.30%
Year-to-Date

Today’s Trading

Previous close156.20
Today’s open169.26
Day’s range166.34 - 181.36
Volume24,346
Average volume (3 months)330,854
Market cap$18.4B
Data as of 4:01pm ET, 06/24/2022

Growth & Valuation

Earnings growth (last year)+20.38%
Earnings growth (this year)+17.04%
Earnings growth (next 5 years)-40.95%
Revenue growth (last year)+280.83%
P/E ratioNM
Price/Sales21.37
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
TEVATeva Pharmaceutical+0.08+0.98%
BBIOBridgeBio Pharma Inc+0.15+1.65%
----
IMMBImmunotech Laborator...0.000.00%
Data as of 4:01pm ET, 06/24/2022

Financials

Next reporting dateAugust 5, 2022
EPS forecast (this quarter)-$3.91
Annual revenue (last year)$1.2B
Annual profit (last year)-$1.4B
Net profit margin-120.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts